Irina V. Kozlova

Irina V. Kozlova

Auto-generated profile, based on publicly available information

Irina V. Kozlova

Krasnov Research Institute of Eye Diseases

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2022 in Russian Open Medical Journal
Verified
Journal Article
Closed access
EOElizaveta R. Orlova
Elizaveta R. Orlova
AGAleksandr V. Gorobets
Aleksandr V. Gorobets
DDDmitry A. Dorofeev
Dmitry A. Dorofeev
EKElena V. Kirilik
Elena V. Kirilik
IKIrina V. Kozlova
Irina V. Kozlova
Background — Intravitreal implants solve a number of serious problems arising in diseases of the posterior segment of the eyeball. Unlike intravitreal injections, the implant provides a prolonged release of a pharmaceutical drug over time. The review presents the characteristics of existing systems for intravitreal drug delivery: nanosystems, non-biodegradable and biodegradable implants. The review also highlights the main advantages and disadvantages of various implants. Based on the conducted literature review, the following conclusion is formulated: the most promising means of targeted drug delivery of drugs to the posterior segment of the eyeball are biodegradable implants. However, currently existing biodegradable implants do not provide entirely controlled release of the drug (uncontrollable extraction episodes occur at times), which constitutes a serious issue requiring improvement. Objective — to summarize the published data on existing systems for the targeted drug delivery into the vitreous chamber, identifying their major advantages and disadvantages. Material and Methods — Information was searched in such databases as PubMed, Google Scholar and ClinicalTrials.gov, using the keywords in both Russian and English languages: intravitreal implants, intraocular implants, biodegradable implants, non-biodegradable implants, nanosystems, nanoparticles, liposomes, targeted drug delivery, posterior segment of the eye, etc.

5 May 2023 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
Sergei AvetisovSergei Avetisov
Sergei Avetisov
VEV.P. Erichev
V.P. Erichev
AAA.A. Antonov
A.A. Antonov
RPR.P. Poleva
R.P. Poleva
IKI.V. Kozlova
I.V. Kozlova
AMA.S. Makarova
A.S. Makarova
Glaucoma is one of the most difficult and significant ocular conditions. The chronic asymptomatic course of glaucoma progression leads to irreversible deterioration of visual functions. Many aspects of its pathogenesis, the features of its clinical presentation, diagnosis and treatment have been identified in recent years. The results of diagnostic methods: tonometry, perimetry, optical coherence tomography — with glaucoma do not have high specificity due to the large diversity of the population. When determining the target intraocular pressure (IOP), we look at the indicators of the choroidal blood flow and biomechanical stress of the cornea and sclera (fibrous membrane of the eye). Studying visual functions is important in the diagnosis and monitoring of glaucoma. The creation of a modern portable device based on a virtual reality helmet allows examination of patients with low central vision. Structural changes in glaucoma affect the optic disc and the inner retinal layers. The proposed classification of atypical discs allows determining the earliest characteristic changes in the neuroretinal rim for glaucoma in cases of difficult diagnosis. The complexity of the diagnosis of glaucoma is also associated with concomitant pathologies in elderly patients. In cases with comorbidity of primary glaucoma and Alzheimer’s disease the structural and functional changes revealed by modern research methods for glaucoma are explained by both the process of secondary transsynaptic degeneration and the death of neurons as a result of an increased IOP. The starting treatment is and its type are fundamentally important for preserving visual functions. Drug therapy with prostaglandin analogues contributes to a significant and persistent decrease in the level of IOP, and mainly by utilizing the uveoscleral outflow pathway. Surgical treatment of glaucoma is an effective way to achieve the target IOP values. However, postoperative hypotension affects the bloodstream both in the central and peripapillary retina. Optical coherence tomography angiography helped establishe that the strongest factor that determines postoperative changes is the difference in IOP, not its absolute level.

23 December 2025 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
DDD.A. Dorofeev
D.A. Dorofeev
IKI.V. Kozlova
I.V. Kozlova
AVA.I. Vereshchagina
A.I. Vereshchagina
Purpose. This study aimed to assess the changes in structural and functional characteristics of the visual analyzer in patients with advanced primary open-angle glaucoma (POAG) in the course of long-term regular use of Retinalamin (Geropharm, Russia). Material and methods. The study was conducted from 2022 to 2024 at two clinical centers: the M.M. Krasnov Research Institute of Eye Diseases and the Chelyabinsk Glaucoma Center. This multicenter cohort prospective study examined the structural and functional parameters of the visual analyzer in patients with advanced POAG during long-term regular use of Retinalamin. The study included a total of 56 patients (98 eyes) divided into two groups. The observation group comprised patients with advanced glaucoma who regularly received 10 intramuscular injections of Retinalamin 5 mg (Geropharm, Russia) diluted in 1.0 mL of 0.9% sodium chloride solution in outpatient setting once every three months over a two-year period. The control group consisted of patients with advanced glaucoma who did not receive neuroprotective therapy. Results. At baseline, all patients in both groups had achieved target intraocular pressure (IOP) through surgical and/or medical treatment, which remained stable throughout the follow-up period. The mean deviation (MD) decreased by 0.98 (0.78; 1.76) dB/year in the observation group and by 1.65 (0.59; 1.79) dB/year in the control group. The pattern standard deviation (PSD) increased by 0.02 (–0.3; 1.2) dB/year in the observation group and by 0.3 (0.7; 1.3) dB/year in the control group. Mean retinal nerve fiber layer (RNFL) thickness showed a similar trend. Following repeated courses of Retinalamin therapy, the observation group demonstrated stable, minimal decrease in RNFL thickness amounting to 1.5 (–0.25; 5.0) μm/year. The control group exhibited more pronounced decrease in RNFL thickness averaging 3.0 (0.75; 10.2) μm/year. Conclusion. Long-term neuroretinoprotective therapy with Retinalamin (Geropharm, Russia) in patients with advanced POAG is justified when administered regularly and the intraocular pressure is stable and well controlled.

11 December 2018 in Russian Ophthalmological Journal
Verified
Journal Article
Open access
PDF file
AAA. A. Antonov
A. A. Antonov
IKI. V. Kozlova
I. V. Kozlova
DKD. V. Kosova
D. V. Kosova
The literary review is focused on reactive hypertension after eye surgeries. Possible causes of increased intraocular pressure are described. Methods of therapy and prevention of reactive hypertension after cataract phacoemulsification and intravitreal injections are analyzed. Literary data show an emphasis on the efficacy and safety of applying a fixed combination of brimonidine and timolol.

1 January 2018 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SPS. Yu. Petrov
S. Yu. Petrov
IKI. V. Kozlova
I. V. Kozlova
VZV. S. Zinina
V. S. Zinina
AVA. V. Volzhanin
A. V. Volzhanin
MKMarina Kravchik
Marina Kravchik
Medical article медицинская статья

1 January 2022 in Russian Annals of Ophthalmology
Verified
Journal Article
Closed access
VEV.P. Erichev
V.P. Erichev
RPR.P. Poleva
R.P. Poleva
ERE.A. Ragozina
E.A. Ragozina
IKI.V. Kozlova
I.V. Kozlova
ЦЕЛЬ ИССЛЕДОВАНИЯ Сравнить гипотензивную эффективность селективной лазерной трабекулопластики (СЛТ) и медикаментозной терапии как стартовых методов у пациентов с впервые выявленной первичной открытоугольной глаукомой (ПОУГ) и офтальмогипертензией. МАТЕРИАЛ И МЕТОДЫ Под наблюдением находилось 30 пациентов (30 глаз) с впервые диагностированной офтальмогипертензией или ПОУГ. Больным 1-й группы (15 глаз) в качестве стартового метода лечения проводили СЛТ по стандартной методике, больным 2-й группы (15 глаз) назначена монотерапия аналогом простагландина. Каждому пациенту измеряли уровень роговично-компенсированного внутриглазного давления (IOPcc) с помощью прибора Ocular Response Analyzer (Reichert Inc., США). Период наблюдения составил 6 мес. РЕЗУЛЬТАТЫ При сроке наблюдения 6 мес тафлупрост эффективно снижал уровень внутриглазного давления в 93,3% случаев, СЛТ — в 73,3% случаев. Не выявлена статистически значимая разница в гипотензивной эффективности двух сравниваемыми методов лечения, которая составила 27,9—28,5% от исходных значений. ЗАКЛЮЧЕНИЕ Селективная лазерная трабекулопластика как стартовый метод лечения первичной открытоугольной глаукомы обладает сопоставимым гипотензивным эффектом по сравнению с медикаментозным режимом при сроке наблюдения 6 мес.